Msn Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SITAGLIPTIN PHOSPHATE MONOHYDRATE USP, with a corresponding US DMF Number 39497.
Remarkably, this DMF maintains an Active status since its submission on March 28, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 14, 2025, and payment made on February 04, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II